CGM

Dexcom G7, the Smallest, Most Accurate, Easy-to-Use CGM Now Connects to the Tandem t:slim X2 Insulin Pump

Retrieved on: 
Wednesday, December 6, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231206143334/en/
    Dexcom G7 CGM now connects with the t:slim X2™ insulin pump by Tandem Diabetes Care in the U.S. (Photo: Business Wire)
    “There’s a reason Dexcom is the undisputed leader in CGM connectivity and the clear choice for AID systems,” said Jake Leach, executive vice president and chief operating officer at Dexcom.
  • Tandem t:slim X2 pumps pre-loaded with Dexcom G7 integration are now shipping to new customers.
  • To learn more and to get started with Dexcom G7 and the Tandem t:slim X2 insulin pump today, visit Dexcom.com/tandem .
  • Dexcom G7 and t:slim X2 insulin pump connectivity is expected to launch in additional countries outside the U.S. in early 2024.

ŌURA Reaches Milestone of 600+ Partnerships and Integrations as It Builds a Large-Scale Ecosystem

Retrieved on: 
Thursday, November 30, 2023

We’ve been steadily building a strong partnership ecosystem and adding world-class features into the ŌURA experience,” said Tom Hale, CEO.

Key Points: 
  • We’ve been steadily building a strong partnership ecosystem and adding world-class features into the ŌURA experience,” said Tom Hale, CEO.
  • “ŌURA is becoming an iconic, global brand that is changing the way we think about long-term health and healthspan.
  • ŌURA is doubling down in specific focus areas with partners across several sectors including women’s health, metabolic health, behavioral health, and fitness and lifestyle.
  • These integrations represent a significant portion of new ŌURA members; additionally, ŌURA members who use Natural Cycles are the highest retaining of all ŌURA cohorts.

Dexcom Unveils Portrait Gallery to Portray Emotional Highs and Lows of Living With Diabetes on World Diabetes Day

Retrieved on: 
Tuesday, November 14, 2023

This press release features multimedia.

Key Points: 
  • This press release features multimedia.
  • Brought to life by creative director, Dexcom Warrior, and Australian model Bambi Northwood-Blyth, and photographed by renowned portrait photographer Fernando Sippel, #SeeDiabetes: The Faces of Diabetes Warriors features Dexcom Warriors from around the world, each living with Type 1 or Type 2 diabetes.
  • Dexcom CGM users whose portraits appear in the gallery include:
    • Beth McDaniel and Ellen Watson, Northern Irish best friends and students
    “As a Dexcom Warrior living with diabetes, it’s an honor to bring to life this unfiltered and genuine representation of what life is like for the millions of people living with diabetes globally,” said Northwood-Blyth.
  • #SeeDiabetes: The Faces of Diabetes Warriors gives people with diabetes a unique platform to continue the global conversation about the need to improve access to critical diabetes care and technology.

Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 9, 2023

U.S. revenue was $3.9 million in the third quarter of 2023 compared to $1.9 million in the prior year period, and revenue outside the U.S. was $2.2 million in the third quarter of 2023 compared to $2.7 million in the prior year period.

Key Points: 
  • U.S. revenue was $3.9 million in the third quarter of 2023 compared to $1.9 million in the prior year period, and revenue outside the U.S. was $2.2 million in the third quarter of 2023 compared to $2.7 million in the prior year period.
  • Third quarter 2023 gross profit of $1.2 million increased from $0.8 million in gross profit for the third quarter of 2022.
  • Third quarter 2023 sales and marketing and general and administrative expenses increased by $0.1 million year-over-year, to $7.4 million.
  • Third quarter 2023 research and development expenses increased by $1.8 million year-over-year, to $12.8 million.

Madoff Trustee Requests Allocation of More Than $66 Million to Customer Fund and Court Approval to Distribute More Than $45 Million to BLMIS Customers with Allowed Claims

Retrieved on: 
Friday, December 8, 2023

"They have the full support of SIPC as well as our thanks for their commitment and accomplishments."

Key Points: 
  • "They have the full support of SIPC as well as our thanks for their commitment and accomplishments."
  • "Our legal team under David Sheehan continues to achieve judicial victories on behalf of Madoff claimants with allowed claims.
  • The aggregate amount distributed to eligible BLMIS customers will total approximately $14.43 billion, including approximately $849.9 million in advances committed by SIPC.
  • The Fifteenth Customer Fund Allocation and Distribution Motion can be found on the United States Bankruptcy Court's website at http://www.nysb.uscourts.gov/ ; Bankr.

TCL CSOT Redefines the Future of Display at Global Display Tech-ecosystem Conference 2023

Retrieved on: 
Friday, December 8, 2023

SHENZHEN, China, Dec. 8, 2023 /PRNewswire/ -- TCL CSOT, a renowned industry player developing advanced, innovative display technologies, launched its Global Display Tech-ecosystem Conference 2023 ("DTC 2023") on December 7 in Wuhan, China.

Key Points: 
  • SHENZHEN, China, Dec. 8, 2023 /PRNewswire/ -- TCL CSOT, a renowned industry player developing advanced, innovative display technologies, launched its Global Display Tech-ecosystem Conference 2023 ("DTC 2023") on December 7 in Wuhan, China.
  • At TCL CSOT, we are dedicated to developing display products that are not only green and low-carbon, but also prioritize eye-friendly features," said Jun Zhao, CEO of TCL CSOT.
  • TCL CSOT (TCL China Star Optoelectronics Technology), established in 2009, is a company committed to developing new technologies and innovations in the display industry.
  • In the future, TCL CSOT will keep devoting itself to technology innovation and providing high-end products for customers and building a vibrant display industry ecosystem.

TCL CSOT Redefines the Future of Display at Global Display Tech-ecosystem Conference 2023

Retrieved on: 
Friday, December 8, 2023

SHENZHEN, China, Dec. 8, 2023 /PRNewswire/ -- TCL CSOT, a renowned industry player developing advanced, innovative display technologies, launched its Global Display Tech-ecosystem Conference 2023 ("DTC 2023") on December 7 in Wuhan, China.

Key Points: 
  • SHENZHEN, China, Dec. 8, 2023 /PRNewswire/ -- TCL CSOT, a renowned industry player developing advanced, innovative display technologies, launched its Global Display Tech-ecosystem Conference 2023 ("DTC 2023") on December 7 in Wuhan, China.
  • At TCL CSOT, we are dedicated to developing display products that are not only green and low-carbon, but also prioritize eye-friendly features," said Jun Zhao, CEO of TCL CSOT.
  • TCL CSOT (TCL China Star Optoelectronics Technology), established in 2009, is a company committed to developing new technologies and innovations in the display industry.
  • In the future, TCL CSOT will keep devoting itself to technology innovation and providing high-end products for customers and building a vibrant display industry ecosystem.

eddii, a gamified diabetes app, is now available in sixteen states across the United States

Retrieved on: 
Tuesday, December 5, 2023

NEW YORK, Dec. 5, 2023 /PRNewswire-PRWeb/ -- eddii, a new diabetes management interface that gamifies real-time glucose data, is pleased to announce its launch in the states of Iowa, South Dakota, North Dakota, Minnesota, Wisconsin, Michigan, Ohio, Indiana, Illinois, and Missouri. By launching in these additional states, eddii plans to increase access to diabetes care for families living in rural areas of the country.

Key Points: 
  • By launching in these additional states, eddii plans to increase access to diabetes care for families living in rural areas of the country.
  • eddii is focusing on supporting children living with diabetes and their families, with plans to expand into the adult market very soon.
  • Earlier this year, eddii also launched in the states of Oklahoma, Texas, Nebraska, Louisiana, Arkansas, and Kansas, with more state releases on the horizon.
  • "We strive to serve families in all parts of the United States who would like easier access to diabetes care.

Ascensia Diabetes Care takes part in MedTech Europe's 'Connecting the Dots' Film Series, with a film on Eversense® CGM

Retrieved on: 
Tuesday, December 5, 2023

Parsippany, N.J.  , Dec. 5, 2023 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, announces its participation in a new film series featuring the story of patient advocate and Eversense® user Troy Ita. Presented by MedTech Europe and including a film produced for the organization by BBC StoryWorks Commercial Productions, the branded content studio of BBC Studios, the 'Connecting the Dots' series brings into focus the evolution of medical technologies, celebrating both cutting-edge innovations and enduring healthcare solutions that empower people. The series is available on www.medtechconnectingthedots.com.

Key Points: 
  • Parsippany, N.J. , Dec. 5, 2023 /PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, announces its participation in a new film series featuring the story of patient advocate and Eversense® user Troy Ita.
  • In particular, the film highlights the transformation that Eversense, the only long-term CGM system, can deliver to people with diabetes, through the lens of Troy and his endocrinologist Dr. Rakesh Patel.
  • In the film, Troy said, "I'm constantly on the road driving for my job, so managing my diabetes has become a juggling act.
  • Ascensia Diabetes Care, the maker of the CONTOUR® Blood Glucose Monitoring (BGM) System portfolio and exclusive distributor of Eversense® Continuous Glucose Monitoring (CGM) Systems, is a PHC Holdings Corporation (TSE: 6523) company.

Kaleido launches cutting-edge Hybrid Closed Loop system with Diabeloop and Dexcom for people with diabetes

Retrieved on: 
Tuesday, November 21, 2023

This system delivers insulin by using the DBLG1 algorithm, which receives input from the Dexcom G6 Continuous Glucose Monitoring (CGM) sensor.

Key Points: 
  • This system delivers insulin by using the DBLG1 algorithm, which receives input from the Dexcom G6 Continuous Glucose Monitoring (CGM) sensor.
  • It combines the convenience of the Kaleido insulin pump with two market-leading innovations designed by Diabeloop and Dexcom to create a Hybrid Closed Loop system for managing type 1 diabetes which is flexible, self-learning and easy to use.
  • Kaleido with DBLG1 and Dexcom G6 improves users' Time in Range by 16.7% 1 , an achievement that should bring real benefits to people with type 1 diabetes.
  • ViCentra is launching the Hybrid Closed Loop system in Germany, the Netherlands and France with its commercial partner Diabeloop.